Carson Wealth (CWM LLC)’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23 Hold
8
﹤0.01% 5628
2025
Q4
$0 Hold
8
﹤0.01% 5636
2025
Q3
$0 Hold
8
﹤0.01% 5537
2025
Q2
$0 Hold
8
﹤0.01% 5303
2025
Q1
$0 Hold
8
﹤0.01% 5201
2024
Q4
$0 Hold
8
﹤0.01% 5160
2024
Q3
$0 Sell
8
-1
-11% -$4 ﹤0.01% 5142
2024
Q2
$0 Hold
9
﹤0.01% 4935
2024
Q1
$0 Hold
9
﹤0.01% 4737
2023
Q4
$0 Hold
9
﹤0.01% 4508
2023
Q3
$0 Hold
9
﹤0.01% 4523
2023
Q2
$1K Hold
9
﹤0.01% 4075
2023
Q1
$1K Hold
9
﹤0.01% 3933
2022
Q4
$1K Buy
+9
New +$1.3K ﹤0.01% 3853
2019
Q1
Sell
-38
Closed -$11K 3263
2018
Q4
$11K Hold
38
﹤0.01% 1313
2018
Q3
$18K Hold
38
﹤0.01% 984
2018
Q2
$17K Hold
38
﹤0.01% 876
2018
Q1
$22K Hold
38
﹤0.01% 691
2017
Q4
$24K Hold
38
﹤0.01% 671
2017
Q3
$35K Hold
38
﹤0.01% 587
2017
Q2
$35K Hold
38
﹤0.01% 538
2017
Q1
$36K Buy
+38
New +$35.4K ﹤0.01% 511

Other funds holding TCRT

Carson Wealth (CWM LLC)'s TCRT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Alaunos Therapeutics (TCRT) position steady in Q1 2026 at 8 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #5628.

Carson Wealth (CWM LLC) first reported a position in TCRT in Q1 2017 and has held it in 22 quarters since. The position peaked at $36K in Q1 2017. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 8 shares of Alaunos Therapeutics worth $23 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Alaunos Therapeutics share count unchanged in Q1 2026.
  • Alaunos Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5628 holding.
  • Carson Wealth (CWM LLC) first reported a position in Alaunos Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • Carson Wealth (CWM LLC)'s Alaunos Therapeutics position peaked at $36K in Q1 2017.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.